|
You are here: Home: BCU 7|2002: Rowan T
Chlebowski, MD, PhD: Select publications
Select publications
Chlebowski RT. Breast cancer risk reduction: Strategies
for women at increased risk. Annu Rev Med 2002;53:519-40.
Abstract
Chlebowski RT et al. American Society of Clinical Oncology
technology assessment on breast cancer risk reduction strategies:
Tamoxifen and raloxifene. J Clin Oncol 1999; 17:1939-55.
Abstract
Chlebowski RT et al. American Society of Clinical Oncology
technology assessment of pharmacologic interventions for breast
cancer risk reduction including tamoxifen, raloxifene and aromatase
inhibition. J Clin Oncol 2002; 20:3328-43. Abstract
Cuzick J. A brief review of the International Breast Cancer
Intervention Study (IBIS), the other current breast cancer prevention
trials, and proposals for future trials. Ann N Y Acad Sci
2001;949:123-33. Abstract
Design of the Women's Health Initiative clinical trial
and observational study. The Women's Health Initiative Study Group.
Control Clin Trials 1998;19(1):61-109. Abstract
Ernst T et al. The effects of tamoxifen and estrogen on
brain metabolism in elderly women. J Natl Cancer Inst 2002;94(8):592-7.
Abstract
Fisher B et al. Tamoxifen for prevention of breast cancer:
Report of the National Surgical Adjuvant Breast and Bowel Project
P-1 Study. J Natl Cancer Inst 1998; 90:1371–87. Abstract
Goodwin PJ et al. Fasting insulin and outcome in early-stage
breast cancer: Results of a prospective cohort study. J
Clin Oncol 2002;20(1):42-51. Abstract
IBIS Investigators. First results from the International
Breast Cancer Intervention Study (IBIS-1): A randomised prevention
trial. Lancet 2002;360:817–24. Abstract
Jones LW et al. A randomized trial of the effects of an
oncologist's recommendation to exercise in newly diagnosed breast
cancer survivors: Preliminary results. Proc ASCO 2002;
Abstract
1417.
Kim DJ. Report from a symposium on diet and breast cancer.
Cancer Causes Control 2002;13(6):591-4.
Powles TJ et al. Interim analysis of the incidence of breast
cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention
trial. Lancet 1998;352:98–101. Abstract
Rock CL, Demark-Wahnefried W. Nutrition and survival after
the diagnosis of breast cancer: A review of the evidence. J
Clin Oncol 2002;20(15):3302-16. Abstract
Schwartz AL. Effect of exercise on bone mineral density
(BMD) in pre- and postmenopausal women receiving chemotherapy for
breast cancer. Proc ASCO 2002;Abstract
1416.
Veronesi U et al. Prevention of breast cancer with tamoxifen:
Preliminary findings from the Italian randomised trial among hysterectomised
women. Lancet 1998;352:93–97. Abstract
Wickerham DL et al. Association of tamoxifen and uterine
sarcoma. J Clin Oncol 2002;20(11):2758-60. Abstract
Wysowski DK et al. Uterine sarcoma associated with tamoxifen
use. N Engl J Med 2002;346(23):1832-3. Abstract
|
